Cargando…
Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
BACKGROUND: Recently, several adaptive one-arm two-stage designs have been developed by fully using the information from previous stages to reduce the expected sample size in clinical trials with binary endpoints as primary outcome. It is important to compute exact confidence limits for these studie...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294881/ https://www.ncbi.nlm.nih.gov/pubmed/28166741 http://dx.doi.org/10.1186/s12874-017-0297-5 |
_version_ | 1782505325435289600 |
---|---|
author | Shan, Guogen Zhang, Hua Jiang, Tao |
author_facet | Shan, Guogen Zhang, Hua Jiang, Tao |
author_sort | Shan, Guogen |
collection | PubMed |
description | BACKGROUND: Recently, several adaptive one-arm two-stage designs have been developed by fully using the information from previous stages to reduce the expected sample size in clinical trials with binary endpoints as primary outcome. It is important to compute exact confidence limits for these studies. METHODS: In this article, we propose three new one-sided limits by ordering the sample space based on p-value, average response rate at each stage, and asymptotic lower limit, as compared to another three existing sample size ordering approaches based on average response rate. Among the three proposed approaches, the one based on the average response rate at each stage is not exact, and the remaining two approaches are exact with the coverage probability guaranteed. RESULTS: We compare these exact intervals by using the two commonly used criteria: simple average length and expected length. The existing three approaches based on average response rate have similar performance, and they have shorter expected lengths than the two proposed exact approaches although the gain is small, while this trend is reversed under the simple average criterion. CONCLUSIONS: We would recommend the two exact proposed approaches based on p-value and asymptotic lower limit under the simple average length criterion, and the approach based on average response rate under the expected length criterion. |
format | Online Article Text |
id | pubmed-5294881 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52948812017-02-09 Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints Shan, Guogen Zhang, Hua Jiang, Tao BMC Med Res Methodol Research Article BACKGROUND: Recently, several adaptive one-arm two-stage designs have been developed by fully using the information from previous stages to reduce the expected sample size in clinical trials with binary endpoints as primary outcome. It is important to compute exact confidence limits for these studies. METHODS: In this article, we propose three new one-sided limits by ordering the sample space based on p-value, average response rate at each stage, and asymptotic lower limit, as compared to another three existing sample size ordering approaches based on average response rate. Among the three proposed approaches, the one based on the average response rate at each stage is not exact, and the remaining two approaches are exact with the coverage probability guaranteed. RESULTS: We compare these exact intervals by using the two commonly used criteria: simple average length and expected length. The existing three approaches based on average response rate have similar performance, and they have shorter expected lengths than the two proposed exact approaches although the gain is small, while this trend is reversed under the simple average criterion. CONCLUSIONS: We would recommend the two exact proposed approaches based on p-value and asymptotic lower limit under the simple average length criterion, and the approach based on average response rate under the expected length criterion. BioMed Central 2017-02-06 /pmc/articles/PMC5294881/ /pubmed/28166741 http://dx.doi.org/10.1186/s12874-017-0297-5 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Shan, Guogen Zhang, Hua Jiang, Tao Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
title | Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
title_full | Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
title_fullStr | Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
title_full_unstemmed | Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
title_short | Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
title_sort | efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294881/ https://www.ncbi.nlm.nih.gov/pubmed/28166741 http://dx.doi.org/10.1186/s12874-017-0297-5 |
work_keys_str_mv | AT shanguogen efficientconfidencelimitsforadaptiveonearmtwostageclinicaltrialswithbinaryendpoints AT zhanghua efficientconfidencelimitsforadaptiveonearmtwostageclinicaltrialswithbinaryendpoints AT jiangtao efficientconfidencelimitsforadaptiveonearmtwostageclinicaltrialswithbinaryendpoints |